A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults
Clinical trial NCT06967181 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06967181
- Sponsor
- CyanVac LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-14
- Primary completion
- 2027-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.